Sign in

    Joseph M. Zubretsky

    President and CEO at Molina Healthcare Inc
    Since November 6, 2017
    Age
    67 years
    Education
    Holds a B.S. in Business Administration from the University of Hartford.
    Tenure
    Has served as the President and Chief Executive Officer at Molina Healthcare, Inc. since November 6, 2017, leading the company’s turnaround and growth initiatives.

    Also at Molina Healthcare Inc

    DJB
    Debra J. Bacon
    EVP, Medicaid
    JEW
    James E. Woys
    Chief Operating Officer (COO)
    JDB
    Jeff D. Barlow
    Chief Legal Officer and Secretary

    About

    Joseph M. Zubretsky is a seasoned executive with over 35 years of experience in strategic, operational, and financial leadership across top companies in the insurance and financial sectors. Born with a strong background in finance, he has successfully navigated multiple senior roles over the years.

    Since joining Molina Healthcare, Inc. on November 6, 2017 as President and CEO, he has been at the forefront of the company’s turnaround and growth strategies. His career includes significant roles such as CEO at The Hanover Group and Healthagen, LLC, as well as various financial leadership positions at Aetna, Inc., Unum Group, Brera Capital Partners, and MassMutual Financial Group.

    In addition to his professional accomplishments, he holds a B.S. in Business Administration from the University of Hartford and is a Certified Public Accountant (inactive), which underlines his strong financial acumen and commitment to excellence. His leadership at Molina Healthcare has been pivotal in steering the organization through transformative change and continued progress.

    $MOH Performance Under Joseph M. Zubretsky

    Past Roles

    OrganizationRoleDate RangeDetails
    The Hanover Insurance Group, Inc. President and Chief Executive Officer June 2016 to October 2017 N/A
    Aetna, Inc. CEO and Senior Executive Vice President of Healthagen, LLC January 2015 to October 2015 N/A
    Aetna, Inc. Senior Executive Vice President of National Businesses February 2013 to December 2014 N/A
    Aetna, Inc. Senior Executive Vice President and Chief Financial Officer November 2010 to February 2013 N/A
    Aetna, Inc. Executive Vice President and Chief Financial Officer March 2007 to November 2010 N/A
    Aetna, Inc. Chief Enterprise Risk Officer April 2007 to February 2013 N/A
    Unum Group Senior Executive Vice President of Finance, Investments, and Corporate Development 2005 to 2007 N/A
    Unum Group Interim Chief Financial Officer 2006 to 2007 N/A
    Brera Capital Partners Special Partner, Chief Investment Officer, and Chief Financial Officer 1999 to 2005 N/A
    MassMutual Financial Group Executive Vice President of Business Development and Chief Financial Officer 1997 to 1999 N/A

    Fixed Compensation

    Data from  FY 2027
    Component NameAmountPayment ScheduleAdditional Details
    Fixed SalaryN/AN/ANo fixed compensation details provided in the documents

    Performance Compensation

    Data from  FY 2027

    Performance Stock Unit Award

    Metric [unit]Value [unit]Details [unit]
    Grant Date [date]August 19, 2024 Award granted with performance period extending through 2027
    Performance Period [date range]August 19, 2024 – December 31, 2027 Period over which adjusted EPS for fiscal 2027 is measured
    Target PSU Shares [shares]146,184 shares Target number of performance units
    Maximum PSU Shares [shares]219,276 shares Maximum shares are 150% of the target
    Performance Metric [indicator]Adjusted Earnings per Share (EPS) for fiscal 2027 EPS goals set in line with the company’s long-term growth rate and strategic plan
    Vesting Conditions [text]0% to 150% vesting based on EPS attainment Must be continuously employed through December 31, 2027; pro-rated vesting on qualifying terminations; additional acceleration available upon a qualifying change in control
    Specific Thresholds/Targets [text]Not disclosed Exact EPS thresholds and weights for vesting are not provided

    Note: No specific dollar amounts are available for the performance component; the details revolve exclusively around share-based awards tied to EPS performance as measured in fiscal 2027.